These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30543885)
1. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression. Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885 [TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity and the mechanism of a green tea (Camellia sinensis) polysaccharide on prostate cancer. Yang K; Gao ZY; Li TQ; Song W; Xiao W; Zheng J; Chen H; Chen GH; Zou HY Int J Biol Macromol; 2019 Feb; 122():95-103. PubMed ID: 30342140 [TBL] [Abstract][Full Text] [Related]
3. [Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2]. Xie S; Xie Y; Zhang Y; Huang Q Yi Chuan; 2014 Jan; 36(1):50-7. PubMed ID: 24846918 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma. Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181 [TBL] [Abstract][Full Text] [Related]
5. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer. Tian X; Zhang Z IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596 [TBL] [Abstract][Full Text] [Related]
6. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2. Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549 [TBL] [Abstract][Full Text] [Related]
8. Disabled homolog 2 is required for migration and invasion of prostate cancer cells. Xie Y; Zhang Y; Jiang L; Zhang M; Chen Z; Liu D; Huang Q Front Med; 2015 Sep; 9(3):312-21. PubMed ID: 26143155 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of Li L; Hao J; Yan CQ; Wang HF; Meng B; Cai SY Cell Cycle; 2020 Nov; 19(21):2793-2810. PubMed ID: 33064976 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2. Min K; Kim JY; Lee SK Int J Biol Sci; 2020; 16(4):694-707. PubMed ID: 32025216 [TBL] [Abstract][Full Text] [Related]
11. MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met. Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z Biomed Pharmacother; 2019 Jan; 109():1406-1410. PubMed ID: 30551391 [TBL] [Abstract][Full Text] [Related]
12. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1. Liang X; Li Z; Men Q; Li Y; Li H; Chong T Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091 [TBL] [Abstract][Full Text] [Related]
13. [Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells]. Zhang Y; Hao T; Zhang H; Wei P; Li X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):247-252. PubMed ID: 29773107 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7. Ren W; Li C; Duan W; Du S; Yang F; Zhou J; Xing J Biochem Biophys Res Commun; 2016 Jan; 469(3):633-8. PubMed ID: 26703210 [TBL] [Abstract][Full Text] [Related]
15. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Du L; Zhao Z; Ma X; Hsiao TH; Chen Y; Young E; Suraokar M; Wistuba I; Minna JD; Pertsemlidis A Oncogene; 2014 Aug; 33(34):4307-15. PubMed ID: 24037530 [TBL] [Abstract][Full Text] [Related]
16. Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2. Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L Int J Oncol; 2017 Jun; 50(6):2033-2042. PubMed ID: 28498390 [TBL] [Abstract][Full Text] [Related]
17. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2. Li Q; Lu S; Li X; Hou G; Yan L; Zhang W; Qiao B Clin Transl Oncol; 2017 May; 19(5):562-570. PubMed ID: 27921232 [TBL] [Abstract][Full Text] [Related]
18. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling. Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452 [TBL] [Abstract][Full Text] [Related]
19. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling. Ren W; Wang D; Li C; Shu T; Zhang W; Fu X Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050 [TBL] [Abstract][Full Text] [Related]
20. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D. Yan L; Yao J; Qiu J Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]